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Abstract
Background: The diagnosis and treatment of latent tuberculosis infection (LTBI) have become mandatory to
reduce the burden of tuberculosis worldwide. Close contacts of active TB patients are at high risk of both active
and LTBI. The aim of this study is to identify the predominant risk factors of contracting LTBI, persons in close
contact with TB patients were recruited. This study also aimed to compare the efficacy of the tuberculin skin test
(TST) and QuantiFERON®-TB GOLD (QFT-G) to diagnose LTBI.
Methods: Close contacts of active pulmonary TB patients visiting a hospital in South Korea were diagnosed for LTBI
using TST and/or QFT-G. The association of positive TST and/or QFT-G with the following factors was estimated:
age, gender, history of Bacillius Calmette-Guerin (BCG) vaccination, history of pulmonary TB, cohabitation status, the
acid-fast bacilli smear status, and presence of cough in source cases.
Results: Of 308 subjects, 38.0% (116/305) were TST positive and 28.6% (59/206) were QFT-G positive. TST positivity
was significantly associated with male gender (OR: 1.734; 95% CI: 1.001-3.003, p =0.049), history of pulmonary TB
(OR: 4.130; 95% CI: 1.441-11.835, p =0.008) and household contact (OR: 2.130; 95% CI: 1.198-3.786, p =0.01) after
adjustment for confounding variables. The degree of concordance between TST and QFT-G was fair (70.4%,
κ =0.392).
Conclusions: A prevalence of LTBI among close contacts of active pulmonary TB patients was high, and prior TB
history and being a household contact were risk factors of LTBI in the study population.
Keywords: Tuberculin test, Interferon-gamma release tests, Latent tuberculosis, Independent living, Tuberculosis,
pulmonary
Background
According to the report of World Health Organization
(WHO), there are about 8.6 million incident cases of tu-
berculosis (TB) and about 1.3 million deaths from TB
annually [1]. A Stop TB Partnership has been established
to reduce the TB burden to less than 100,000 cases per
year by 2050 by focusing on areas of high TB burden [2].
However, persons in close contacts with TB patients are
also at a risk of contracting latent TB infection (LTBI).
In 2010, the WHO estimates that nearly 1/3 of the
world’s population contracted LTBI, and that 10% of
these carriers will develop an active TB infection [3].
The vast majority of these patients will become infec-
tious and perpetuate the cycle of morbidity and mortal-
ity. Therefore, it is imperative to diagnose LTBI patients
early and efficiently to reduce the global burden of TB.
The traditional method to diagnose TB infection is tu-
berculin skin test (TST). However, this test does not dis-
criminate LTBI patients. The FDA recently approved the
use of interferon gamma release assays (IGRAs) such as
the QuantiFERON-TB Gold® (QFT-G) assay for the diag-
nosis of LTBI [4]. In 2011, Korean guidelines stipulate
that IGRAs are an alternative method of TST for the
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diagnosis of LTBI [5]. IGRAs have some advantages over
TST. First, IGRAs lack booster effect. Second, BCG vac-
cination and infection by non-tuberculosis mycobacte-
rium (NTM) has less effect on the IGRA than on the
TST. Third, the patients don’t need to revisit for reading
the results [6]. There are several risk factors known to
be associated with developing active TB in close con-
tacts, including malnutrition, untreated LTBI, being a
household contact, age under 5 years, acid-fast bacilli
(AFB) positivity of source case, concomitant human im-
munodeficiency virus infection, and immunocomprom-
ised status [7,8]. However, there is limited data about
risk factors for LTBI in close contacts.
The present study was conducted to identify the pre-
dominant risk factors of contracting the latent form of
the disease and to compare the efficiency of the TST and
QFT-G to diagnose LTBI subjects in close contacts of
active pulmonary TB patients.
Methods
Subjects and study design
All data presented in this study were acquired during an
international multi-center study (title: A Randomized
Clinical Trial Comparing 4RIF vs. 9INH for Treatment
of Latent Tuberculosis Infection – Effectiveness, Regis-
tration number; NCT00931736). The primary objective
of the multi-center study is to compare the effectiveness
of two regimens in preventing active tuberculosis. Full
details of the original study are provided in the study
protocol, see Section 2 in the Additional file 1: Appendix.
In this study, close contacts of culture-positive pulmonary
TB patients who visited Gyeongsang National University
Hospital, Jinju, South Korea, were prospectively enrolled
between October 2009 and August 2012. Close contacts
are recommended to visit a hospital because screening of
close contacts is a national policy project in South Korea.
The current study was approved by the Gyeongsang
National University Hospital Institutional Review Board
(approval number IRB-2009-042). Close contact was de-
fined as exposure to AFB smear-positive and/or culture-
positive active pulmonary TB patient during their infectious
period for at least 4 hours per week. The duration of expos-
ure was determined by self-reported questionnaire. House-
hold contacts were defined as those living in the same
house with source case. Exclusion criterion was active TB
identified by chest X-ray. The remaining subjects filled in-
formed consent documents and were tested for LTBI by
TST and/or QFT-G. Both tests were conducted on the
same day or TST was conducted first. We also documented
seven potential risk factors for LTBI: age, gender, history of
Bacillus Calmette-Guerin (BCG) vaccination, history of pul-
monary TB, living in the same house with a TB patient, the
presence of cough, and AFB smear status of the source
case. By interviewing enrolled subjects and source patients,
age, gender, history of tuberculosis in the close contacts
and cough symptom of source case were recorded. History
of BCG vaccination was verified by BCG scar. The previous
history of TB was identified by self-reported question-
naire. Level of contact was categorized into household
or non-household.
TST and QFT-G
TST was conducted by Mantoux method using puri-
fied protein derivative (PPD, Statens Serum Institute;
Copenhagen, Denmark). The subjects were given an
intradermal injection of Tuberculin (2 units in 0.1 ml)
on the forearm. Transverse diameter of induration was
measured and recorded in millimeters between 48 and
72 hours. TST was considered positive when indur-
ation size was equal to or greater than 5 mm according
to the cut-off value of the multi-center study. Induration
was read by skilled and trained physicians. QFT-G test
(Cellestis Ltd, Carnegie, VIC, Australia) was carried out
according to the manufacturer’s instructions. Briefly,
whole blood was collected and aliquots were incubated
for 16 to 24 hours with TB-specific antigens, including
early secretory antigenic target 6-kda protein (ESAT-6)
and culture filtrate protein 10 (CFP-10). The concentra-
tion of released IFN-γ was measured by enzyme-linked
immunosorbent assay (ELISA) [9,10].
Statistical analysis
Descriptive statistics were used to assess the correlation
between the seven potential risk factors and TST and/or
QFT-G positivity. Each variable was analyzed using a
Pearson’s Chi-square test. Risk of having LTBI for each
potential risk factor was estimated using multinomial lo-
gistic regression. Kappa (κ) statistics were used to meas-
ure concordance between TST and QFT-G and classified
as follows: κ ≤0 = no agreement; 0 < κ ≤0.2 = poor agree-
ment; 0.2 < κ ≤0.4 = fair agreement; 0.4 < κ ≤0.6 =moder-
ate agreement; 0.6 < κ ≤0.8 = substantial agreement;
0.8 < κ ≤1.0 = optimal agreement. Differences were con-
sidered statistically significant if p <0.05. Statistical ana-
lyses were performed using SPSS version 18.0 for Window
(SPSS Inc, Chicago, Illinois, USA).
Results
LTBI in the study population
The review of 129 cases of active TB patients identified a
total of 308 close contact individuals (103 males and 205
females) confirmed not to have active TB by chest X-
rays (Table 1). Subjects were household or work contacts
of patients with confirmed active pulmonary TB. TST
was administered and read for 305 subjects of whom
116 (38.0%) had a positive result. QFT-G was carried out
in 206 subjects of whom 59 (28.6%) showed a positive
result. Both tests were completed in 203 subjects of
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whom 138 subjects underwent both tests on the same
day. QFT-G was conducted later in 65 subjects and me-
dian interval between both tests was 3 days. More than
90% of the subjects had a BCG vaccination (94.4% in the
TST group, 94.2% in the QFT-G group). A total of 7.2%
subjects from the TST group and 7.3% subjects from the
QFT-G group had a history of previous active pulmon-
ary TB. AFB staining of smear of source cases was posi-
tive in 77.4% in the TST group and 73.8% in the QFT-G
group. A total of 53.8% subjects in the TST group and
51.0% subjects in the QFT-G group were household
contacts. Presence of cough in source cases was 60.3%
in the TST group and 58.7% in the QFT-G group
(Table 1). Comorbid conditions included hypertension
in 21, diabetes in 8, cardiovascular disease in 7, thyroid
disease in 7, chronic liver disease in 5 subjects (data
not shown).
Risk factors for LTBI
The three potential risk factors that were not associated
with TST- or QFT-positivity were as follows: history of
BCG vaccination, cough and AFB smear status of source
case (Table 2). Age was associated with TST positivity
when stratified into 10-year old, but not with QFT-G
positivity. Occurrence of positive TST was significantly
higher in males than in females, but there was no signifi-
cant difference in the occurrence of positive QFT-G be-
tween males and females. Both TST- and QFT-positivity
were significantly associated with being a household
contact. Subjects with history of TB showed significantly
higher TST and QFT-G positivity than those without TB
(Table 2).
Multivariate logistic regression was performed with ei-
ther TST- or QFT-positivity as the dependent variable
and the seven risk factors as independent variables (Table 3).





(n = 305) (n = 206)
Demographics
Male 103 (33.8%) 66 (32.0%)
Age (Mean ± SD) 44.2 ± 15.1 43.7 ± 14.7
15 - 24 28 (9.2%) 19 (9.2%)
25 - 34 61 (20.0%) 42 (20.4%)
35 - 44 75 (24.6%) 52 (25.2%)
45 - 54 72 (23.6%) 48 (23.3%)
55 - 64 41 (13.4%) 29 (14.1%)
≥ 65 28 (9.2%) 16 (7.8%)
Household contact
Yes 164 (53.8%) 105 (51.0%)
Test result
Positive 116 (38.0%) 59 (28.6%)
BCG vaccination scar
Yes 288 (94.4%) 194 (94.2%)
History of pulmonary TB
Yes 22 (7.2%) 15 (7.3%)
AFB smear status of source
cases
Positive 236 (77.4%) 152 (73.8%)
Cough of source cases
Yes 184 (60.3%) 121 (58.7%)
TB Tuberculosis, BCG Bacillus of Calmette-Guerin, TST Tuberculin skin test,
QFT-G QuantiFERON® TB GOLD.
Table 2 Association of seven potential risk factors with
TST or QFT-G positivity
TST positive,
n (%)
p value QFT-G positive,
n (%)
p value
Age < 0.001 0.063
15 – 24 2 (7.1) 2 (10.5)
25 – 34 16 (26.2) 6 (14.3)
35 – 44 39 (52.0) 19 (36.5)
45 – 54 34 (47.2) 16 (33.3)
55 – 64 16 (39.0) 10 (34.5)
≥ 65 9 (32.1) 6 (37.5)
Gender 0.001 0.176
Male 53 (51.5) 23 (34.8)




Yes 108 (37.5) 53 (27.3)
No 8 (47.1) 6 (50.0)
Household contact 0.023 0.033
Yes 72 (43.9) 37 (35.2)




Yes 16 (72.7) 8 (53.3)




Positive 95 (40.3) 48 (31.6)




Yes 78 (42.4) 40 (33.1)
No 38 (31.4) 19 (22.4)
TB Tuberculosis, BCG Bacillus of Calmette-Guerin, TST Tuberculin skin test,
QFT-G QuantiFERON®-TB GOLD.
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Male gender, history of pulmonary TB and household con-
tact significantly increased odds ratio of TST positivity
(Table 3). There was definitely no gender difference in
QFT-G positivity, but there was a trend toward QFT-G
positivity associated with history of pulmonary TB and
household contact. These results suggest that prior TB his-
tory and being a household contact are the predominant
risk factors for LTBI.
Concordance between TST and QFT-G
Among total of 308 participants, 305 subjects performed
TST and 206 subjects performed QFT-G testing. Two-
hundred-three subjects completed both TST and QFT-G
testing. Among them, 46 subjects were positive for both
TST and QFT-G, 49 subjects were TST positive but QFT-
G negative, 11 subjects were QFT-G positive but TST
negative, and 97 subjects were negative for both tests.
Concordance rate of two tests was 70.4%. The kappa value
showed fair agreement (κ = 0.392), but showed a signifi-
cant correlation between two tests (p <0.001, Table 4).
Discussion
This study showed that positive rate of TST and QFT-G
is high in those who are in close contact with active
pulmonary TB patients. History of TB and household
contact were significantly associated with the risk of
TST positivity and concordance between TST and QFT-
G was 70.4%.
The prevalence of LTBI is expected to be high in close
contacts of active TB patients. The prevalence of LTBI in
close contacts was reported to be highest among many
risk groups for LTBI, including close contacts, foreign-
born people, homeless people, injection drug users, and
prisoners [11]. Furthermore, close contact is one of the
common risk factor for progression from LTBI to active
disease [11]. In the present study, the positive rates of
TST and QFT-G were 38.0% and 28.6% respectively, in
South Korean population. Marks et al. reported that a
prevalence of LTBI is about 36% in close contacts of per-
sons with infectious TB as assessed by TST in a study
conducted in the United States [12]. Meanwhile, the
prevalence of LTBI in household contacts in countries
with a high burden of TB is diversely reported from 27%
to 93%, again based on TST [13]. The positive rate of
QFT-G in contact investigation for TB was 30.2% in
Germany and 19% in Taiwan [14,15]. Given that South
Korea has an intermediate burden of TB cases and almost
every child receives BCG vaccination at birth, the positive
rates of both tests in this study, especially of QFT-G, were
considerably high. In a previous multi-center study con-
ducted in South Korea, the positive rate of QFT-G in
health care workers was 17.2% and that of TST was 36.7%
[16]. Because QFT-G is not affected by the previous BCG
vaccination and most of the NTM infection, high positive
rate of QFT-G in this study reconfirms the incidence of
LTBI in close contacts of active TB patients is quite high
in South Korean population.
Table 3 Multivariate analysis between seven risk factors and TST or QFT-G positivity
TST positivity QFT-G positivity
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
Gender (male) 1.734 (1.001-3.003) 0.049 0.982 (0.476-2.025) 0.961
Age
15 – 24 1 1
25 – 34 6.373 (1.273-31.909) 0.024 1.495 (0.267-8.360) 0.647
35 – 44 13.769 (2.865-66.172) 0.001 4.103 (0.809-20.820) 0.088
45 – 54 10.552 (2.221-50.141) 0.003 3.081 (0.607-15.625) 0.174
55 – 64 6.597 (1.307-33.284) 0.022 3.070 (0.555-16.975) 0.199
≥ 65 2.089 (0.284-15.379) 0.470 1.340 (0.134-13.355) 0.803
BCG vaccination scar (yes) 0.335 (0.067-1.681) 0.184 0.361 (0.055-2.370) 0.289
History of pulmonary TB (yes) 4.130 (1.441-11.835) 0.008 2.561 (0.819-8.002) 0.106
Household contact (yes) 2.130 (1.198-3.786) 0.010 1.911 (0.920-3.971) 0.083
Smear status of source case (positive) 1.460 (0.745-2.864) 0.271 1.947 (0.831-4.564) 0.125
Cough of source case (yes) 1.324 (0.753-2.328) 0.329 1.167 (0.576-2.362) 0.669
TB Tuberculosis, BCG Bacillus of Calmette-Guerin, TST Tuberculin skin test, QFT-G QuantiFERON®-TB GOLD, CI Confidence interval.
Table 4 Correlation between TST and QFT-G (n =203)
QFT-G
Positive Negative κ p value Agreement, %
TST Positive 46 49
Negative 11 97 0.392 <0.001 70.4
TST Tuberculin skin test, QFT-G QuantiFERON®-TB GOLD.
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Increasing age was significantly associated with TST
positivity, but not with QFT-G positivity in the current
study. Li et al. reported that prevalence of TST positivity
significantly increased with age [17]. Furthermore, ac-
cording to the reports of Pareek et al. and Shanaube et al.,
the result of QFT-G as well as that of TST was associated
with increasing age [18,19]. It is uncertain whether
increased age is the risk factor of contracting LTBI or
whether increased cumulative exposure to Mycobacterium
tuberculosis and/or NTM as people grow older increases
positivity of both tests.
Active TB is reported to be more prevalent in men
than in women, but reasons for this phenomenon are
uncertain due to the lack of studies about gender differ-
ences in patients with TB. Gender differences in patients
with LTBI were also not studied much. In our study,
male gender significantly increased relative risk of TST
positivity but not of QFT-G positivity. More data will be
needed to clarify the influence of gender in the incidence
of LTBI.
The occurrence of LTBI in close contacts with previ-
ous pulmonary TB history was significantly high in this
study. We aimed to assess the association between previ-
ous history of pulmonary TB and the risk of contracting
LTBI because the impact of previous history of pulmon-
ary TB on the LTBI had not been well studied. TST and
QFT-G are methods to measure lasting adaptive im-
mune responses to Mycobacterium tuberculosis rather
than to identify LTBI directly [20]. Direct identification
of LTBI was impossible until recently. Although IGRA is
a officially approved test for the diagnosis of LTBI, Kim
et al. reported that IGRA has a limited role in the diag-
nosis of TB infection in individuals with a history of TB
[21]. Thus, it is uncertain whether positive results of
TST and QFT-G depend on the presence of living myco-
bacteria or persistent immune responses of previous TB
infection. Nevertheless, close contacts of active TB pa-
tients are at a high risk of infection, and QFT-G is sug-
gested to detect INF-γ released by effector T-cells rather
than memory T-cells within a short period of incubation
[22,23]. It is therefore mandatory to study the effects of
previous TB history on LTBI, including through clinical
trials, and to understand the molecular basis of T-cell
responses.
Household contact increased the risk of TST- and
IGRA-positivity in previous studies [24,25]. Likewise, the
result of current study showed that household contact
significantly increased relative risk of being TST positive
and QFT-G was tend to be more positive in household
contacts. It is therefore reasonable to pay particular at-
tention to household contacts during the contact investi-
gation of active TB.
The agreement and kappa values of concordance of
TST and IGRA have been reported widely in TB contacts
[9,15,26]. The common outcome of those studies is that
BCG vaccination lowered the agreement between the two
tests. In one study performed in Denmark, in which about
two-thirds of enrolled subjects were not vaccinated with
BCG, the agreement between TST and QFT-G was 94%
(κ = 0.866) [9]. In contrast, most of the people in Korea
receive BCG vaccine, and the agreement of two tests in
this study was much lower (70.4%, κ = 0.392). In this
study, only 11 of 203 subjects who received both tests
were not vaccinated with BCG. Thus, subgroup analysis
for non-BCG vaccinated people did not show significant
results (data not shown). Additionally, high rate of BCG
vaccination lowered the statistical power to assess the im-
pact of BCG vaccination on TST or QFT-G. In this study,
11 subjects were QFT-G positive but TST negative. The
result of QFT-G might be false positive even though we
could not verify the baseline result of QFT-G before con-
tact to active TB patients. Performing QFT-G test repeat-
edly will be helpful to clarify this issue.
While designing this study, we assumed that smear
status and presence of cough in source cases might be
important factors influencing the occurrence of LTBI.
However, our results show that none of these were risk
factors. Therefore, the limitations of this study are as fol-
lows. First, the number of enrolled subjects is relatively
small because people in Korea are not aware of the con-
cept of LTBI and the importance of screening contacts
of TB patients. The knowledge about LTBI needs to be
spread among the Korean people. Second, of the 308 en-
rolled subjects, only 203 subjects were willing to take
both TST and QFT-G tests, because we gave them an
option of choosing between TST and/or QFT-G accord-
ing to the Korean guidelines. Both single screening strat-
egy using TST or IGRA and dual screening strategy
using TST and subsequent IGRA were recommended in
the Korean guidelines. Third, in 65 among 203 subjects
who took both tests, QFT-G was conducted later than
TST and in 28 among those 65 subjects, the interval be-
tween two tests was over 4 days. Van Zyl-Smit et al. have
reported that a booster effect of PPD was evident by day
7 post-TST, but not by day 3 [27]. The booster effect of
PPD might have caused false-positive results of QFT-G
in some of the subjects in this study. Fourth, the level of
contact was not categorized in depth. In particular, in
subjects who were a household contact, whether they lived
in the same room or not would be an important factor in-
fluencing their LTBI risk.
Conclusions
LTBI is prevalent in close contacts of active pulmonary
TB patients in a South Korean population, and history
of pulmonary TB and being a household contact are
predominant risk factors of contracting LTBI in this
study.
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